Clinical use of β2-adrenergic receptor agonists based on their intrinsic efficacy

Allergology International

Volumn 54, Issue 1, 2005, Pages 89-97

  Kume, Hiroaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Airway smooth muscle; Bronchial asthma; Desensitization; Gs; Long acting 2 agonists; Rho; 2 adrenergic receptors

Indexed keywords

ADENYLATE CYCLASE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FORMOTEROL; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; METHACHOLINE; PROCATEROL; RHO KINASE; SALBUTAMOL; SALMETEROL; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; THEOPHYLLINE; TULOBUTEROL;

AIRWAY; ASTHMA; DESENSITIZATION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG USE; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE RELAXATION; TRACHEA MUSCLE;

EID: 17044431102     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.2332/allergolint.54.89     Document Type: Review

References (44)

1. Sears M, Taylor DR, Print CG et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336:1391-1396.
2. Barnes PJ. Beta-adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med. 1995;152:838-860.
3. Townley RG. Beta-adrenergic receptors and mechanisms in asthma: The new long-acting beta-agonists. Allergol. Int. 1996;45:13-22.
4. Wills-Karp M, Uchida Y, Lee JY, Jinot J, Hirata A, Hirata F. Organ culture with proinflammatory cytokines reproduces impairment of the β-adrenoceptor-mediated relaxation in tracheas of a guinea pig antigen model. Am. J. Respir. Cell Mol. Biol. 1993;8:153-159.
5. Koto H, Mak JCW, Haddad E-B et al. Mechanisms of impaired of β-adrenoceptor-induced airway relaxation by interleukin-1 β in vivo in the rat. J Clin. Invest. 1996;98:1780-1787.
6. Ishikawa T, Kume H, Kondo M, Ito Y, Yamaki K, Shimokata K. Inhibitory effects of interferon-γ on the hetrologous desensitization of β-adrenoceptors by transforming growth factor-β1 in tracheal smooth muscle. Clin. Exp. Allergy 2003;33:808-815.
7. 2+ sensitization in tracheal smooth muscle. Am. J. Respir. Cell Mol. Biol. 2001;25:291-298.
8. Bai TR. Abnormalities in airway smooth muscle in fatal asthma. Am. Rev. Respir. Dis. 1990;141:552-557.
9. Hadcock JR, Malbon CC. Regulation of β-adrenergic receptors by "permissive" hormones: glucocorticoids increase steady-state levels of receptor mRNA. Proc. Natl. Acsd. Sci. USA 1988;85:8415-8419.
10. 2-agonists and corticosteroids. Eur. Respir. J. 2002;19:182-191.
11. Booth H, Bish R, Walters J, Whitehead F, Walter EH. Salmeterol tachyphylaxis in steroid treated asthmatic subjects. Thorax 1996;51:1100-1104.
12. 2-agonists. Am. J. Respir. Crit. Care Med. 1996;154:1603-1607.
13. Grainger J, Woodman K, Pearce N et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax 1991;46:105-111.
14. Ca channels in human trachealis. Am. J. Respir. Crit. Care Med. 1999;159:452-460.
15. Kume H, Takagi K. Inhibitory effects of Gs on desensitization of β-adrenergic receptors in tracheal smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol 1997;273:L 556-564.
16. 2-adrenergic receptor. J. Biol. Chem. 1989;264:16786-16792.
17. Bouvier M, Hausdroff WP, De Blasi A et al. Removal of phosphorylation sites from the β-adrenergic receptor dalays onset of agonist-promoted desensitization. Nature 1988;333:370-373.
18. Benovic JL, Strasser RH, Caron MG, Lefkowitz RJ. β-Adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc. Natl. Acad. Sci. USA 1986;83:2797-2801.
19. Inglese J, Freedman NJ, Koch WJ, Lefkowitz RJ. Structure and mechanism of G protein-coupled receptor kinase. J. Biol. Chem. 1993;268:23735-23738.
20. 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J. Biol. Chem. 1989;264:12657-12665.
21. 2AR-adenylyl cyclase pathway in human smooth muscle. Am. J. Respir. Cell Mol. Biol. 1998;19:338-348.
22. Ca channels in airway smooth muscle by cAMP-dependent and -independent mechanisms. J. Clin. Invest. 1994;93:371-379.
23. Kume H, Takagi K, Satake T, Tokuno H, Tomita T. Effects of intracellular pH on calcium-activated potassium channels in rabbit tracheal smooth muscle. J. Physiol. 1990;424:445-457.
24. Hiramatsu T, Kume H, Kotlikoff MI, Takagi K. Role of calcium-activated potassium channels in the relaxation of tracheal smooth muscles by forskolin. Clin. Exp. Pharmacol. Physiol. 1994;21:367-375.
25. +-channel activity in tracheal myocytes by phosphorylation. Nature 1989;341:152-154.
26. Kume H, Graziano MP, Kotlikoff MI. Stimulatory and inhibitory regulation of calcium-activated potassium channels by guanine nucleotide-binding proteins. Proc. Natl. Acad. Sci. USA 1992;89:11051-11055.
27. Mizutani H, Kume H, Ito Y, Takagi K, Yamaki K. Differential effects of β-adrenoceptor desensitization on inhibitory actions in guinea-pig trachealis. Clin. Exp. Pharmacol. Physiol. 2002;29:646-654.
28. Sudo Y, Kume H, Ito S, Ito Y, Yamaki K, Takagi K. Effects of direct and indirect activation of G protein of adenylyl cyclase on the subsequent response to β-adrenergic receptor agonists in human trachealis. Arzneim-Forsch. 2002;52:803-812.
29. 2+ mobilization in tachyphyaxis to β-adrenergic receptors in trachealis. Am. J. Respir. Cell Mol. Biol. 2003;29:359-366.
30. Hanania NA, Sharafkhaneh A, Roger B, Dickey BF. β-Agonist intrinsic efficacy: management and clinical significance. Am. J. Respir. Crit. Care Med. 2002;165:1353-1358.
31. Whaley BS, Yuan N, Birmbaumer L, Clark RB, Barber R. Differential expression of β-adrenergic receptos modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. Mol. Pharmacol. 1994;45:481-489.
32. Lemoine H, Overlack C. Highly potent beta-2 sympathomimetics convert to less potent partial agonists as relaxants of guinea pig tracheae maximally contracted by carbachol. Comparison of relaxation with receptor binding and adenylate cyclase stimulation. J. Pharmacol. Exp. Ther. 1992;261:258-270.
33. 2- adrenoceptor. Br. J. Pharmacol. 1998;123:701-711.
34. 2-Adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists. J. Biol. Chem. 1997;272:23871-23879.
35. Ca channels in the muscarinic and β-adrenergic regulation of airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol 1995;268:L221-229.
36. Kume H, Kondo M, Ito Y, Suzuki R, Yamaki K, Takagi K. Effects of sustained-release tulobuterol on asthma control and β-adrenoceptor function. Clin. Exp. Pharmacol. Physiol. 2002;29:1076-1083.
37. Clark RB, Knoll BJ, Barber R. Partial agonists and G protein-coupled receptor desensitization. TiPS 1999;20:279-286.
38. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N. Engl. J. Med. 1992;327:1198-1203.
39. Pearlman DS, Chervinsky P, LaForce C et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N. Engl. J. Med. 1992;327:1420-1425.
40. Tan KS, Grove A, Mclean A, Gnosspelius Y, Hall IP, Lipworth BJ. Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am. J. Respir. Crit. Care Med. 1997;156:28-35.
41. Pauwels RA, Lofdahl CG, Postma DS et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 1997;337:1405-1411.
42. Palmqvist M, Ibsen T, Meilen A, Lotvall J. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients. Am. J. Respir. Crit. Care Med. 1999;160:244-249.
43. Nelson HS, Berkowitz RB, Tinkelman DA, Emmett AH, Richard KA, Yancy SW. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma. Am. J. Respir. Clin. Care Med. 1999;159:1556-1561.
44. Korosec M, Novak RD, Myers E, Skowronski M, McFadden ER. Salmeterol does not compromise the bronchodilator response to albuterol during acute episodes of asthma. Am. J. Med. 1999;107:209-213.